Academic Journal
Prior percutaneous coronary intervention and outcomes in patients after coronary artery bypass grafting: a meta-analysis of 308,284 patients
| Title: | Prior percutaneous coronary intervention and outcomes in patients after coronary artery bypass grafting: a meta-analysis of 308,284 patients |
|---|---|
| Authors: | Hongliang Zhang, Zhenyan Zhao, Jing Yao, Jie Zhao, Tao Hou, Moyang Wang, Yanlu Xu, Bincheng Wang, Guannan Niu, Yonggang Sui, Guangyuan Song, Yongjian Wu |
| Source: | Therapeutic Advances in Chronic Disease, Vol 13 (2022) |
| Publisher Information: | SAGE Publishing, 2022. |
| Publication Year: | 2022 |
| Collection: | LCC:Therapeutics. Pharmacology |
| Subject Terms: | Therapeutics. Pharmacology, RM1-950 |
| More Details: | Background: The association between prior percutaneous coronary intervention (PCI) and prognosis after coronary artery bypass grafting (CABG) remains uncertain. We aimed to evaluate the aforementioned association in a meta-analysis. Methods: PubMed, Cochrane’s Library, and Embase databases were searched for potential studies. A random-effects model was used for the meta-analysis. Meta-regression was performed to evaluate the influence of study characteristics on the outcomes. Results: Thirty-six follow-up studies with 308,284 patients were included, and 40,892 (13.3%) patients had prior PCI. Pooled results showed that prior PCI was associated with higher risks of early (in-hospital or within 1 month) all-cause mortality [odds ratio (OR): 1.26, 95% confidence interval (CI): 1.11–1.44, p = 0.003; I 2 = 64%] and major adverse cardiovascular events (MACEs; OR: 1.36, 95% CI: 1.12–1.66, p = 0.002, I 2 = 79%), but not with late (follow-up durations from 1 to 13 years) mortality (OR: 1.03, 95% CI: 0.95–1.13, p = 0.44, I 2 = 46%) or MACEs (OR: 1.03, 95% CI: 0.97–1.09, p = 0.38, I 2 = 0%). Meta-regression showed that the study characteristics of patient number, age, sex, diabetic status, and proportion of patients with prior PCI did not affect the outcomes. Sensitivity analyses limited to multivariate studies excluding patients with acute PCI failure showed similar results (early mortality, OR: 1.25, p = 0.003; early MACE, OR: 1.50, p = 0.001; late mortality, OR: 1.03, p = 0.70). Conclusion: The current evidence, mostly from retrospective observational studies, suggests that prior PCI is related to poor early clinical outcomes, but not to late clinical outcomes, after CABG. |
| Document Type: | article |
| File Description: | electronic resource |
| Language: | English |
| ISSN: | 2040-6231 20406223 |
| Relation: | https://doaj.org/toc/2040-6231 |
| DOI: | 10.1177/20406223221078755 |
| Access URL: | https://doaj.org/article/0ded344337e54670bd971d4d23739dff |
| Accession Number: | edsdoj.0ded344337e54670bd971d4d23739dff |
| Database: | Directory of Open Access Journals |
| ISSN: | 20406231 20406223 |
|---|---|
| DOI: | 10.1177/20406223221078755 |
| Published in: | Therapeutic Advances in Chronic Disease |
| Language: | English |